Skip to main content
. 2024 Feb 19;11:1366769. doi: 10.3389/fmed.2024.1366769

Table 5.

RECQL VUSs in the distribution of subgroups based on pathological classification.

Group Number With BRCA1/2 With BRCA1/2, PALB2
Invasive ductal carcinoma 47 28 19
Carcinoma in situ 3 2 1
Total 50 30 20